US FDA approves Amgen drug for small cell lung cancer, Health News, ET HealthWorld
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
small
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
